Texas Man Files Risperdal Lawsuit Alleging Gynecomastia Complications, Case Now Pending in Pennsylvania Litigation
A Risperdal lawsuit alleging gynecomastia, or male breast growth, allegedly caused by a widely-used antipsychotic medication has been filed in Pennsylvania state court, court records indicate.
According to an update listed on the website of the Philadelphia Court of Common Pleas, the case was filed on September 20th by a man from Texas who allegedly grew breast tissue after taking Risperdal for three years. The medication, used to treat schizophrenia and bipolar disorder in children and adults, has been at the center of rising litigation recently. The plaintiff in this case is now seeking compensation for the physical, emotional and psychological injuries he claims to have sustained. In addition to allegations of male breast growth, Risperdal lawsuit includes claims of weight gain and pre-diabetes.
Manufactured by Janssen Pharmaceuticals Inc., Risperdal is approved to treat irritability in children with autistic disorder between 5 and 16. In an increasing number of cases, the medication has been prescribed off-label to treat ADHD, research shows.
Several Risperdal Lawsuits Filed in Consolidated Pennsylvania Litigation
Risperdal lawsuit claims alleging gynecomastia, or male breast growth, are currently pending in a consolidated litigation underway in Pennsylvania’s Philadelphia Court of Common Pleas. In October 2012, Johnson & Johnson agreed to settle five cases over the medication. Several of these cases allege that mastectomies and/or liposuction may be necessary to repair Risperdal complications.
Symptoms of Rispedal gynecomastia include pain, swelling, tenderness, and nipple discharge in one or both breasts.
Research May Lend Evidence to Risperdal Gynecomastia Claims
A 2006 study published in the Journal of Clinical Psychopharmacology showed that some children taking Risperdal had higher levels of prolactin, a hormone associated with breast development in girls and new mothers. In 2009, the Journal of Adolescent Psychopharmacology found that elevated levels of prolactin may last up to two years.
Risperdal lawsuits allege that Johnson & Johnson concealed its knowledge that the drug may cause gynecomastia in men and young boys, but failed to warn the general public.
How to File a Risperdal Lawsuit
The lawyers at Bernstein Liebhard LLP are actively investigating potential Risperdal cases on behalf of men or boys who developed gynecomastia, or male breast growth, after taking the antipsychotic medication for a prolonged period of time. As the Firm is currently offering free and confidential case evaluations to anyone who may fall under this category, call us today at (877) 779-1414.